Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.
about
Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerDisparities in Gynecological MalignanciesProspective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study.Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.The effect of neighborhood disadvantage on the racial disparity in ovarian cancer-specific survival in a large hospital-based study in cook county, illinois.Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tamponsCervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.Identification of a peptide specifically targeting ovarian cancer by the screening of a phage display peptide libraryGynecologic cancer outcomes in the elderly poor: A population-based study.Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980-2013): an analysis of population-based data in relation to socioeconomic changes.Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.Health Disparities in Native Hawaiians and Other Pacific Islanders Following Hysterectomy for Endometrial CancerOveruse of external beam radiotherapy for stage I endometrial cancerThe National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income CountriesAvailability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and WhitesEnterolactone has stronger effects than enterodiol on ovarian cancer.Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap?Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?MicroRNAs in gynecological cancers: Small molecules with big implications.Surgical wait time: A new health indicator in women with endometrial cancer.Molecular analysis of isolated tumor glands from endometrial endometrioid adenocarcinomas.Racial health disparities in ovarian cancer: not just black and white.Application of non-Gaussian water diffusional kurtosis imaging in the assessment of uterine tumors: A preliminary study.Rural-urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients.Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.Demographic, presentation, and treatment factors and racial disparities in ovarian cancer hospitalization outcomes.Correlations between Risk Factors for Breast Cancer and Genetic Instability in Cancer Patients—A Clinical Perspective Study.HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use.Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 TrialRace and nodal disease status are prognostic factors in patients with stage IVB cervical cancer
P2860
Q26750563-3632E611-11D8-4C26-B2F4-F2B991ACBF74Q26768263-E0A9FFBE-1ACC-4754-8359-33614CFA546EQ30354788-3C99275E-6DC6-4170-A476-B6F29A72781BQ33808855-4B1DEB5C-056D-4659-B9CE-8374A62D2DC0Q34998433-BFFB4CF5-D751-452A-91A8-9E8EC657A176Q35235853-72606073-F6DB-41EE-A3A2-9E6108375D36Q35469502-98EAE155-A0D9-41DD-999C-3D2D902D4A15Q36055188-48D63566-F4C4-4D50-91F6-4913A812E942Q36117707-B8B5CFEC-50C6-46B1-9267-2E64EA2468CFQ36142237-68E4570E-9437-4095-BEDF-885DA38F6A41Q36414088-00660F93-5480-4BF4-B5E7-E9900B8C5632Q36915033-7BE8F965-0AF4-483A-B5A8-C0472E13AF44Q37038694-40F67687-849E-442A-8686-EBE2E36E0D76Q37313606-6A2034FA-B5EF-4A5F-B47F-A836983A37F8Q38613569-49C9FEAB-46F7-4836-85D0-2FAF0BD07BFAQ38696508-AC1DCB0E-07B7-4CA0-849C-21C66EE5E0CFQ38759017-7F045DA5-96F3-41B4-A285-75978E5DA768Q38861948-4F0B0467-A073-4D99-ABB7-BF67A5A939F7Q38984023-71FA818F-57FF-4743-A83F-02E60068619AQ39309053-034D739C-28FC-414E-90CE-0C28A240D974Q39333266-77F01B02-1D90-4609-84DD-9E17401D1717Q39831758-A6C3C8AF-740D-44E1-BE11-3ECAA6185DB6Q41138341-F581AD81-A01B-4189-A0FA-E8E59667BDCDQ41696304-8C509DF2-AD5E-41E3-9B78-CA7D2F3051B3Q47104042-80B3BD39-7CAA-4847-939E-892612DD420EQ47241035-7FA2F596-C691-47B7-BBCB-F9FAE63EB802Q47619776-EB2D48F7-E698-475C-AF02-B60CBEFCB571Q48140746-2FDD1527-1B25-4A13-BFE0-E73C16AD085BQ50079344-8B82238E-642B-4D68-BBFC-F05EE706E5ACQ50334835-4A36FD01-0DA7-4B60-962F-E85623784B74Q50891269-133931BB-9424-43CE-B15B-D5562EA201CCQ57493790-582D18C5-788E-4177-9D52-A3BAB92307EFQ58080932-71B36F6D-2DB6-4441-B552-319672180B44Q58767926-189FA0DA-ADB0-413A-B373-88F117C7415B
P2860
Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@ast
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@en
type
label
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@ast
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@en
prefLabel
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@ast
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@en
P2093
P2860
P1433
P1476
Gynecologic cancer disparities ...... ciety of Gynecologic Oncology.
@en
P2093
Dineo Khabele
Eloise Chapman-Davis
John H Farley
Yvonne Collins
P2860
P304
P356
10.1016/J.YGYNO.2013.12.039
P407
P577
2014-01-07T00:00:00Z